Apotheek Debackere Leen SRL
Apotheek Debackere Leen reported total assets of 354,864 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Apr 2026).
The score of Apotheek Debackere Leen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -14 % Total assets -59 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Debackere Leen's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 25 Apr 2026
- Year ended 30 Sep 2024filed on 30 Apr 2025
- Year ended 30 Sep 2023filed on 04 Apr 2024
- Year ended 30 Sep 2022filed on 27 Apr 2023
- Year ended 30 Sep 2021filed on 08 Apr 2022
Apotheek Debackere Leen's financial analysis
- Solvency70.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Debackere Leen
Apotheek Debackere Leen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0884.217.158
- VAT number
- BE0884217158
- Peppol
- Registered · 0208:0884217158 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Oct 2006
- Registered office
- 9881 Aalter
- Latest accounts
- 2025 · filed on 25 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Debackere Leen (SRL) has been based in Aalter since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 1,560 € and equity of 251,427 €; its revenue is not published. Its solvency stands at 70.9%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Debackere Leen
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie des Pagodes Manufacture of basic pharmaceutical products Genappe · balance sheet 383,064 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- Temmerman Retail sale of pharmaceutical products Ghent · balance sheet 349,257 €
- I & CM Patriotes Retail sale of pharmaceutical products Brussels · balance sheet 322,247 €
- Apham Retail sale of pharmaceutical products Antwerp · balance sheet 398,276 €
- JLS Pharma Retail sale of pharmaceutical products La Bruyère · balance sheet 232,526 €
- Smets Pharma Retail sale of pharmaceutical products Lier · balance sheet 452,862 €
- Medicuro Retail sale of pharmaceutical products Stekene · balance sheet 457,159 €
Frequently asked questions about Apotheek Debackere Leen
What is the revenue of Apotheek Debackere Leen?
Apotheek Debackere Leen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Debackere Leen?
In Belgium, the VAT number is the company number prefixed with BE: BE0884217158 for Apotheek Debackere Leen, if the company is VAT-registered. Its company number (CBE) is 0884.217.158.
Where is the registered office of Apotheek Debackere Leen?
According to the CBE register, the registered office of Apotheek Debackere Leen is in 9881 Aalter.
What is the equity of Apotheek Debackere Leen?
At the close of the 2025 financial year, the equity of Apotheek Debackere Leen amounts to 251,427 €, a solvency of 70.9% of total assets.
Who manages Apotheek Debackere Leen?
The register lists 1 active mandates at Apotheek Debackere Leen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Debackere Leen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →